 This study will enroll stroke patients that have severe hemiparesis of an upper limb as defined by 1 an UE-FMA score of less than or equal to 19 and 2 a Chedoke McMaster Stage of 1-2 for the arm and hand. Three cohorts of patients enrolled in the study will include: 